ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

PTGX Protagonist Therapeutics Inc

25.075
-0.485 (-1.90%)
Last Updated: 09:31:59
Delayed by 15 minutes

Period:

Draw Mode:

Volume 41,979
Bid Price 25.06
Ask Price 25.10
News -
Day High 25.44

Low
13.72

52 Week Range

High
33.34

Day Low 25.00
Share Name Share Symbol Market Stock Type
Protagonist Therapeutics Inc PTGX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.485 -1.90% 25.075 09:31:59
Open Price Low Price High Price Close Price Previous Close
25.25 25.00 25.44 25.56
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,035 41,979 US$ 25.25 US$ 1,060,078 - 13.72 - 33.34
Last Trade Type Quantity Price Currency
09:31:38 100 US$ 25.075 USD

Protagonist Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.48B 58.27M - 60M -78.96M -1.35 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Protagonist Therapeutics News

Date Time Source News Article
4/16/202408:00GlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of..
3/01/202419:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/01/202419:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
3/01/202419:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
3/01/202415:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/29/202416:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
2/28/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
2/27/202415:12Edgar (US Regulatory)Form 8-K - Current report
2/14/202406:47Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202406:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
1/31/202415:05Edgar (US Regulatory)Form 8-K - Current report
1/18/202419:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No PTGX Message Board. Create One! See More Posts on PTGX Message Board See More Message Board Posts

Historical PTGX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week26.7127.7824.2225.45449,056-1.64-6.12%
1 Month27.7429.2124.2226.92527,783-2.67-9.61%
3 Months26.0033.3424.2228.20574,535-0.925-3.56%
6 Months14.3833.3413.7624.22700,11210.7074.37%
1 Year22.6033.3413.7223.08803,4412.4810.95%
3 Years29.4650.546.9121.02983,109-4.39-14.88%
5 Years10.3250.544.4719.78762,78714.76142.97%

Protagonist Therapeutics Description

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. The Company operates and manages its business as one operating segment.

Your Recent History

Delayed Upgrade Clock